相关实验视频
Updated: Mar 10, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
39名患有自身免疫性肺气膜膜蛋白酶症的患者的临床特征
1Department of Respiratory Medicine, Fuzhou Pulmonary Hospital, China.
肺膜蛋白质症 (PAP) 是一种罕见的肺部疾病. 全肺洗是最有效的治疗方法,各种生物标志物与疾病严重程度相关.
科学领域:
- 肺部病理学 肺部病理学
- 内部医学 内部医学
- 放射学 放射学是一门学科.
背景情况:
- 肺膜蛋白质症 (PAP) 是一种罕见的扩散性肺部疾病,其特点是表面活性剂在肺中积累.
- 临床表现往往是非特异性的,带来了诊断挑战.
研究的目的:
- 探索自身免疫性肺膜蛋白质病的临床表现,检查结果,诊断方法和治疗疗效.
- 改善临床医生对PAP的理解和诊断能力.
主要方法:
- 对39名被诊断患有自身免疫性PAP的患者的临床数据的回顾性分析.
- 分析各种生物标志物 (乳酸脱酶,动脉部分氧气压,瘤标志物) 与PAP疾病严重程度之间的相关性.
- 对相关医学文献的审查.
主要成果:
- 常见的症状包括咳和呼吸短促. 胸部CT通常显示"类似地图"或"疯狂铺路"的模式.
- 肺功能测试经常显示扩散和受限通风功能障碍.
- PAP疾病严重程度得分与乳酸脱酶,肺气膜动脉氧气差压和几个瘤标志物 (CEA,CYFRA 21-1,NSE,CA15-3) 有正相关.
- 疾病严重程度与动脉部分氧气压力和一氧化碳扩散能力负相关.
- 动脉部分氧气压和肺膜动脉氧气差压与瘤标志物和扩散能力有复杂的相关性.
结论:
- 自身免疫性肺膜蛋白质症是一种罕见的扩散性肺病,具有非特异性临床特征.
- 全肺大容量膜洗是最有效的治疗方法.
- 动脉部分氧气压,肺膜动脉氧气差压,乳酸脱酶,瘤标志物和一氧化碳扩散能力与PAP严重程度相关.
更多相关视频
09:15Author Spotlight: Optimized Protocol for Detecting Antigen-Specific T Cells in Mouse Lungs Using Tetramers
Published on: July 19, 2024
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia II: Pathophysiology
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction